Evidence map›Paper›PMID 30413728›Full record

ArticleScientific reports2018

Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons.

Neus Bayó-Puxan, Ana Paula Terrasso, Sophie Creyssels, Daniel Simão, Christina Begon-Pescia, Marina Lavigne, Sara Salinas, Florence Bernex, Assumpció Bosch, Vasiliki Kalatzis and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Generation of Donor-Specific iPSC for Modelling Lysosomal Storage Disorders.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Patient-Derived Breast Cancer Tissue Cultures for Anti-Endocrine Drug Assays.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  13. Article
  14. THAP1 modulates oligodendrocyte maturation by regulating ECM degradation in lysosomes.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 5 countries.

Neus Bayó-PuxanInstitute de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.
Ana Paula TerrassoiBET - Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
Sophie CreysselsInstitute de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.
Daniel SimãoiBET - Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
Christina Begon-PesciaInstitute de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.
Marina LavigneInstitute de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.
Sara SalinasInstitute de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.
Florence BernexIRCM, Inserm, University Montpellier, Montpellier, France.
Assumpció BoschDepartament Bioquímica i Biologia Molecular, and Center of Animal Biotechnology and Gene Therapy (CBATEG), Universitat Autònoma Barcelona, Bellaterra, Spain.
Vasiliki KalatzisINM, Inserm, University Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0002-9626-8807
Thierry LevadeLaboratoire de Biochimie Métabolique, IFB, CHU Purpan, and Inserm 1037, CRCT, University Paul Sabatier Toulouse-III, Toulouse, France.
Ana Maria CuervoDepartment of Developmental and Molecular Biology and Institute for Aging Studies, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID http://orcid.org/0000-0002-0771-700X
Philippe LoryIGF, CNRS, Inserm, University Montpellier, Montpellier, France.
Antonella ConsiglioDepartment of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Institute of Biomedicine of the University of Barcelona (IBUB), Barcelona, Spain.
Catarina BritoiBET - Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal. anabrito@ibet.pt.
Eric J KremerInstitute de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.
Centre National de la Recherche Scientifique · FRInstituto de Biologia Experimental e Tecnológica · PTInserm · FRAlbert Einstein College of Medicine · USBellvitge University Hospital · ESUniversitat Autònoma de Barcelona · ESUniversité Toulouse III - Paul Sabatier · FR

Funding

Role of Autophagy in T Cell Function and Immunosenescence (Project 3)P01AG031782 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CUERVO, ANA MARIA · 2009 to 2024
$36.2M
Einstein's Nathan Shock Center of Excellence in Basic Biology of AgingP30AG038072 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HUFFMAN, DEREK MAJOR · 2010 to 2024
$10.8M
Decreased Protein Degradation in AgingR37AG021904 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CUERVO, ANA MARIA · 2013 to 2022
$4.4M
Understanding Alzheimer's Disease in the Context of the Aging BrainRF1AG054108 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CUERVO, ANA MARIA · 2016 to 2016
$2.1M
EC | European Research Council (ERC) 2012-StG-311736-PD-HUMMODELEuropean Commission (EC) FP7 BrainCAV 222992NIA NIH HHS P30 AG038072NIA NIH HHS R37 AG021904NIA NIH HHS RF1 AG054108
6 · The paper itself

Abstract

Mucopolysaccharidosis type VII (MPS VII) is a lysosomal storage disease caused by deficient β-glucuronidase (β-gluc) activity. Significantly reduced β-gluc activity leads to accumulation of glycosaminoglycans (GAGs) in many tissues, including the brain. Numerous combinations of mutations in GUSB (the gene that codes for β-gluc) cause a range of neurological features that make disease prognosis and treatment challenging. Currently, there is little understanding of the molecular basis for MPS VII brain anomalies. To identify a neuronal phenotype that could be used to complement genetic analyses, we generated two iPSC clones derived from skin fibroblasts of an MPS VII patient. We found that MPS VII neurons exhibited reduced β-gluc activity and showed previously established disease-associated phenotypes, including GAGs accumulation, expanded endocytic compartments, accumulation of lipofuscin granules, more autophagosomes, and altered lysosome function. Addition of recombinant β-gluc to MPS VII neurons, which mimics enzyme replacement therapy, restored disease-associated phenotypes to levels similar to the healthy control. MPS VII neural cells cultured as 3D neurospheroids showed upregulated GFAP gene expression, which was associated with astrocyte reactivity, and downregulation of GABAergic neuron markers. Spontaneous calcium imaging analysis of MPS VII neurospheroids showed reduced neuronal activity and altered network connectivity in patient-derived neurospheroids compared to a healthy control. These results demonstrate the interplay between reduced β-gluc activity, GAG accumulation and alterations in neuronal activity, and provide a human experimental model for elucidating the bases of MPS VII-associated cognitive defects.

Indexed as

Neural PathwaysCase-Control StudiesCell DifferentiationCells, CulturedGlycosaminoglycansHumansInduced Pluripotent Stem CellsLysosomesMucopolysaccharidosis VIINeuronsStem CellsGlycosaminoglycans

Identifiers

PMID30413728
PMCPMC6226539
OpenAlexW2899769042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.